GH Research PLC (GHRS)
GHRS trades on Nasdaq in Health Care, Biotechnology: Pharmaceutical Preparations. Numbers below come from the Nasdaq screener and SEC filings, each with its source.
Price · October 14, 2026
$18.85
-5.84% on the day
Market cap
$1.3B
Small cap
Revenue
Foreign filer: no machine-readable annual figure in SEC data
Net income
Foreign filer: no machine-readable annual figure in SEC data
Price, change, market cap, sector and industry: Nasdaq stock screener, as of October 14, 2026.
Profile
| Field | Value |
|---|---|
| Ticker | GHRS on Nasdaq |
| Sector | Health Care |
| Industry | Biotechnology: Pharmaceutical Preparations |
| Country | Ireland |
| IPO year | 2021 |
| SEC CIK | 0001855129 |
| SEC industry code | Pharmaceutical Preparations |
| Incorporated in | L2 |
Financials
Foreign filer: no machine-readable annual figure in SEC data.
Key SEC documents
| Document | Form | Filed |
|---|---|---|
| Latest prospectus or offering document | F-3 | 2026-05-14 |
| Latest annual report | 20-F | 2026-03-05 |
| Latest quarterly / interim | 6-K | 2026-10-09 |
Source: SEC EDGAR submissions feed, 199 recent filings. All filings on EDGAR.
Price moves
| Window | Return |
|---|---|
| 1 week | -11.7% |
| 1 month | -32.5% |
| 3 months | -36.1% |
| Year to date | +46.5% |
| 1 year | +43.5% |
| From 52-week high | -39.3% |
Source: Yahoo Finance daily closes, last bar 2026-10-14. Computed by Sophia Capital from daily closes; cap, sector and tier from the Nasdaq screener.
Peers in Biotechnology: Pharmaceutical Preparations
| Ticker | Company | Price | Day | Market cap |
|---|---|---|---|---|
| NKTR | Nektar Therapeutics | $37.92 | -4.82% | $1.3B |
| TYRA | Tyra Biosciences Inc. | $18.56 | -5.31% | $1.3B |
| SNDX | Syndax Pharmaceuticals Inc. | $13.95 | -15.71% | $1.2B |
| ANAB | AnaptysBio Inc. | $45.59 | -0.98% | $1.3B |
| OMER | Omeros Corporation | $18.88 | -3.82% | $1.4B |
| KARD | Kardigan Inc. | $12.97 | -9.62% | $1.2B |
| RAPP | Rapport Therapeutics Inc. | $28.99 | -3.85% | $1.4B |
| KLRA | Kailera Therapeutics Inc. | $10.77 | -4.94% | $1.4B |
The full dossier has every filing, three years of financials, private raises and the people who signed them.
Open the full dossier